Operating Expenses
Share-Based Compensation Expense
Thermo Fisher Scientific Share-Based Compensation Expense decreased by 1.2% to $83.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $75.00M to $83.00M. Over 4 years (FY 2021 to FY 2025), Share-Based Compensation Expense shows an upward trend with a 7.7% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
Metric ID:
axp_share_based_compensation_expenseHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $51.00M | $51.00M | $77.00M | $78.00M | $77.00M | $77.00M | $75.00M | $76.00M | $74.00M | $67.00M | $61.00M | $70.00M | $84.00M | $68.00M | $79.00M | $75.00M | $81.00M | $70.00M | $84.00M | $83.00M |
| QoQ Change | — | +0.0% | +51.0% | +1.3% | -1.3% | +0.0% | -2.6% | +1.3% | -2.6% | -9.5% | -9.0% | +14.8% | +20.0% | -19.0% | +16.2% | -5.1% | +8.0% | -13.6% | +20.0% | -1.2% |
| YoY Change | — | — | — | — | +51.0% | +51.0% | -2.6% | -2.6% | -3.9% | -13.0% | -18.7% | -7.9% | +13.5% | +1.5% | +29.5% | +7.1% | -3.6% | +2.9% | +6.3% | +10.7% |
Range$51.00M – $84.00M
CAGR+10.8%
Avg YoY Growth+7.6%
Median YoY Growth+2.2%
Share-Based Compensation Expense at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's share-based compensation expense?
- Thermo Fisher Scientific (TMO) reported share-based compensation expense of $83.00M in Q1 2026.
- How has Thermo Fisher Scientific's share-based compensation expense changed year-over-year?
- Thermo Fisher Scientific's share-based compensation expense increased by 10.7% year-over-year, from $75.00M to $83.00M.
- What is the long-term trend for Thermo Fisher Scientific's share-based compensation expense?
- Over 4 years (2021 to 2025), Thermo Fisher Scientific's share-based compensation expense has grown at a 7.7% compound annual growth rate (CAGR), from $230.00M to $310.00M.